Patent details

Basic Information

Publication number:

EP2901856

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151539541

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Immunostimulatory oligonucleotide multimers

French Title of Invention:

Multimères d'oligonucléotides immunostimulateurs

German Title of Invention:

Immunstimulatorische Oligonukleotidmultimere

SPC Number:

Dates

Filing date:

15/06/2005

Grant date:

09/08/2017

EP Publication Date:

05/08/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/08/2017

EP B1 Publication Date:

09/08/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/06/2018

Expiration date:

15/06/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/08/2017

 

 

Name:

Idera Pharmaceuticals, Inc.

Address:

345 Vassar Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

Kandimalla, Ekambar

Address:

United States (US)

2

Name:

Yu, Dong

Address:

United States (US)

3

Name:

Agrawal, Sudhir

Address:

United States (US)

Priority

1

Priority Number:

579985 P

Priority Date:

15/06/2004

Priority Country:

United States (US)

2

Priority Number:

599362 P

Priority Date:

06/08/2004

Priority Country:

United States (US)

Classification

IPC classification:

A01N 43/04; A61K 9/68; A61K 31/70; C07H 21/02; C07H 21/04;

Publication

European Patent Bulletin

Issue number:

201732

Publication date:

09/08/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/10/2018	Outgoing Correspondence	1